A new clinical trial will explore gene editing for sickle cell disease
Verywell Health: Umut Gurkan, the Warren E. Rupp Associate Professor in the Department of Mechanical and Aerospace Engineering, said that medication treatment options for sickle cell disease have been fairly limited for decades.